The PAI-1 4G/5G Gene Polymorphism and Ischemic Stroke: An Association Study and Meta-Analysis

Journal of Stroke and Cerebrovascular Diseases

Volumn 16, Issue 4, 2007, Pages 173-179

  Attia, John ^a,b   Thakkinstian, Ammarin ^a   Wang, Yang ^b   Lincz, Lisa ^c   Parsons, Mark ^b   Sturm, Jonathan ^d   McGettigan, Patricia ^c   Scott, Rodney ^e   Meldrum, Cliff ^e   Levi, Christopher ^b  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b JOHN HUNTER HOSPITAL   (Australia)

^c NEWCASTLE MATER HOSPITAL   (Australia)

^d GOSFORD HOSPITAL   (Australia)

^e JOHN HUNTER HOSPITAL   (Australia)

Author keywords

cerebrovascular accident; genetic association study; genetic polymorphisms; plasminogen activator inhibitor type 1; Stroke; tissue type plasminogen activator

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR;

AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; ALLELES; BRAIN ISCHEMIA; CARRIER PROTEINS; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; MUTAGENESIS, INSERTIONAL; NEW SOUTH WALES; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE DELETION;

EID: 34447253783     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2007.03.002     Document Type: Article

References (37)

1. Loskutoff D.J. Regulation of PAI-1 gene expression. Fibrinolysis 5 (1991) 197-206
2. Dawson S.J., Wiman B., Hamsten A., et al. The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem 268 (1993) 10739-10745
3. Eriksson P., Kallin B., Hooft F., et al. Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci 92 (1995) 1851-1855
4. Festa A., D'Agostino Jr. R., Rich S.S., et al. Promoter (4G/5G) plasminogen activator inhibitor-1 genotype and plasminogen activator inhibitor-1 levels in blacks, Hispanics, and non-Hispanic whites: The Insulin Resistance Atherosclerosis Study. Circulation 107 (2003) 2422-2427
5. Panahloo A., Mohamed-Ali V., Lane A., et al. Determinants of plasminogen activator inhibitor 1 activity in treated NIDDM and its relation to a polymorphism in the plasminogen activator inhibitor 1 gene. Diabetes 44 (1995) 37-42
6. Roest M., and Banga J.D. Editorial comment: Genetic make-up for increased PAI-1 expression protects against stroke. Stroke 34 (2003) 2828-2829
7. Boekholdt S.M., Bijsterveld N.R., Moons A.H.M., et al. Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction: A systematic review. Circulation 104 (2001) 3063-3068
8. Wiklund P.-G., Nilsson L., Ardnor S.N., et al. Plasminogen activator inhibitor-1 4G/5G polymorphism and risk of stroke: Replicated findings in two nested case-control studies based on independent cohorts. Stroke 36 (2005) 1661-1665
9. Bang C.O., Park H.K., Ahn M.Y., et al. 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and insertion/deletion polymorphism of the tissue-type plasminogen activator gene in atherothrombotic stroke. Cerebrovasc Dis 11 (2001) 294-299
10. Crainich P., Jenny N.S., Tang Z., et al. Lack of association of the plasminogen activator inhibitor-1 4G/5G promotor polymorphism with cardiovascular disease in the elderly. J Thromb Haemost 1 (2003) 1799-1804
11. Jood K., Ladenvall P., Tjärnlund-Wolf A., et al. Fibrinolytic gene polymorphism and ischemic sroke. Stroke 36 (2005) 2077-2081
12. Hindorff L.A., Schwartz S.M., Siscovick D.S., et al. The association of PAI-1 promoter 4G/5G insertion/deletion polymorphism with myocardial infarction and stroke in young women. J Cardiovasc Risk 9 (2002) 131-137
13. van Goor M.L., Garcia E.G., Leebeek F., et al. The plasminogen activator inhibitor (PAI-1) 4G/5G promoter polymorphism and PAI-1 levels in ischemic stroke: A case-control study. Thromb Haemost 93 (2005) 92-96
14. Catto A.J., Carter A.M., Stickland M., et al. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphism and levels in subjects with cerebrovascular disease. Thromb Haemost 77 (1997) 730-734
15. Chen C.H., Eng H.L., Chang C.J., et al. 4G/5G promoter polymorphism of plasminogen activator inhibitor-1, lipid profiles, and ischemic stroke. J Lab Clin Med 142 (2003) 100-105
16. Hoekstra T., Geleijnse J.M., Kluft C., et al. 4G/4G genotype of PAI-1 gene is associated with reduced risk of stroke in elderly. Stroke 34 (2003) 2822-2828
17. Petrovic D., Milananez T., Kobal J., et al. Prothrombotic gene polymorphisms and atherrombotic cerebral infarction. Acta Neurol Scand 108 (2003) 109-113
18. Endler G., Lalouschek W., Exner M., et al. The 4G/4G genotype at nucleotide position −675 in the promotor region of the plasminogen activator inhibitor 1 (PAI-1) gene is less frequent in young patients with minor stroke than in controls. Br J Haematol 110 (2000) 469-471
19. Kain K., Young J., Bamford J., et al. Determinants of plasminogen activator inhibitor-1 in South Asians with ischaemic stroke. Cerebrovasc Dis 14 (2002) 77-83
20. Ladenvall P., Wall U., Jern S., et al. Identification of eight novel single-nucleotide polymorphisms at human tissue-type plasminogen activator (t-PA) locus: Association with vascular t-PA release in vivo. Thromb Haemost 84 (2000) 150-155
21. Wolf A.T., Medcalf R.L., and Jern C. The t-PA -7351C→T enhancer polymorphism decreases Sp1 and Sp3 protein binding affinity and transcriptional responsiveness to retinoic acid. Blood 105 (2005) 1060-1067
22. Ladenvall P., Johansson L., Jansson J.H., et al. Tissue-type plasminogen activator -7351C/T enhancer polymorphism is associated with a first myocardial infarction. Thromb Haemost 87 (2002) 105-109
23. Jannes J., Hamilton-Bruce M., Pilotto L., et al. Tissue plasminogen activator -7351C/T enhancer polymorphism is a risk factor for lacunar stroke. Stroke 35 (2004) 1090-1094
24. Hatano S. Experience from a multicenter stroke register: A preliminary report. Bull World Health Organ 54 (1976) 541
25. Adams Jr. H.P., Bendixen B.H., Kappelle L.J., et al. Classification of subtype of acute ischemic stroke: Definitions for use in a multicenter clinical trial. TOAST (Trial of Org 10172 in Acute Stroke Treatment). Stroke 24 (1993) 35-41
26. Tirschwell D.L., Longstreth Jr. W.T., Becker K.J., et al. Shortening the NIH Stroke Scale for use in the prehospital setting. Stroke 33 (2002) 2801-2806
27. Scandinavian Stroke Study Group. Multicenter trial of hemodilution in ischemic stroke: Background and study protocol. Stroke 16 (1985) 885-890
28. Wang Y., Lim L.L.-Y., Levi C., et al. The influence of admission body temperature on stroke mortality. Stroke 31 (2000) 404-409
29. Weir C.J., Murray G.D., Dyker A.G., et al. Is hyperglycemia an independent predictor of poor outcome after acute stroke?. Results of a long-term follow-up study. BMJ 314 (1997) 1303-1306
30. Margaglione M., Grandone E., Cappucci G., et al. An alternative method for PAI-1 promoter polymorphism (4G/5G) typing. Thromb Haemost 77 (1997) 605-606
31. Cuzick J. Wilcoxon-type test for trend. Stat Med 4 (1985) 87-90
32. Mohr J.P., Albers G.W., Amarenco P., et al. Etiology of stroke. Stroke 28 (1997) 1501-1506
33. Catto A.J., Kohler H.P., Bannan S., et al. Factor XIII Val 34 Leu: A novel association with primary intracerebral hemorrhage. Stroke 29 (1998) 813-816
34. Jood K., Ladenvall C., Resengren A., et al. Family history in ischemic stroke before 70 years of age. Stroke 36 (2005) 1383-1387
35. Zhan M., Zhou Y.L., and Han Z.C. Plasminogen activator inhibitor-1 4G/5G gene polymorphism in patients with myocardial or cerebrovascular infarction in Tianjin, China. Chin Med J 116 (2003) 1707-1717
36. Ding Z., and Pan J. Distribution of PAI-1 promoter 4G/5G polymorphism in healthy Chinese and functional characterization using a luciferase reporter vector. Ann Hematol 84 (2005) 183-187
37. Wong T.Y.H., Poon P., Szeto C.C., et al. Association of plasminogen activator inhibitor-1 4G/4G genotype and type 2 diabetic nephropathy in Chinese patients. Kidney Int 57 (2005) 632-638